Aridis Pharmaceuticals Inc. (ARDS) Shares Spiking Higher on Major Volume on News of Grant from Gates Foundation

January 27, 2022 7:22 AM EST
Get Alerts ARDS Hot Sheet
Price: $1.07 +4.90%

Overall Analyst Rating:
    BUY (= Flat)

Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Aridis Pharmaceuticals Inc. (NASDAQ: ARDS) shares are advancing significantly higher on large volume in early pre-market trading, following announcement that the company received a grant award from the Bill & Melinda Gates Foundation to evaluate the application of Aridis' inhaled formulation technology to deliver cost-effective monoclonal antibodies (mAbs) against influenza and SARS-CoV2 to people in low- and middle-income countries

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Momentum Movers, Trader Talk

Related Entities

Bill & Melinda Gates Foundation Trust